- Home
- ATNM vs LSF Comparison
ATNM vs LSF Comparison
Compare ATNM & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- LSF
- Stock Information
- Founded
- ATNM 2000
- LSF 2015
- Country
- ATNM United States
- LSF United States
- Employees
- ATNM N/A
- LSF N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- LSF Packaged Foods
- Sector
- ATNM Health Care
- LSF Consumer Staples
- Exchange
- ATNM Nasdaq
- LSF Nasdaq
- Market Cap
- ATNM 46.5M
- LSF 55.5M
- IPO Year
- ATNM N/A
- LSF 2020
- Fundamental
- Price
- ATNM $1.21
- LSF $5.27
- Analyst Decision
- ATNM Strong Buy
- LSF Strong Buy
- Analyst Count
- ATNM 4
- LSF 2
- Target Price
- ATNM $8.75
- LSF $7.75
- AVG Volume (30 Days)
- ATNM 1.4M
- LSF 73.0K
- Earning Date
- ATNM 04-29-2025
- LSF 05-07-2025
- Dividend Yield
- ATNM N/A
- LSF N/A
- EPS Growth
- ATNM N/A
- LSF N/A
- EPS
- ATNM N/A
- LSF N/A
- Revenue
- ATNM N/A
- LSF $43,295,137.00
- Revenue This Year
- ATNM N/A
- LSF $22.58
- Revenue Next Year
- ATNM N/A
- LSF $20.06
- P/E Ratio
- ATNM N/A
- LSF N/A
- Revenue Growth
- ATNM N/A
- LSF 26.50
- 52 Week Low
- ATNM $1.03
- LSF $1.90
- 52 Week High
- ATNM $10.24
- LSF $10.90
- Technical
- Relative Strength Index (RSI)
- ATNM 43.76
- LSF 44.60
- Support Level
- ATNM $1.18
- LSF $5.00
- Resistance Level
- ATNM $1.34
- LSF $5.51
- Average True Range (ATR)
- ATNM 0.15
- LSF 0.47
- MACD
- ATNM -0.03
- LSF 0.01
- Stochastic Oscillator
- ATNM 11.99
- LSF 44.96
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.